Donald Tomalia

Donald Tomalia was the scientific director of the Center for Biologic Nanotechnology at the University of Michigan Medical School.He earned an undergraduate degree from the University of Michigan, a master's degree from Bucknell University and a Ph.D. in physical organic chemistry from Michigan State University. He worked at Dow Chemical for many years as a research scientist. In 1979, Tomalia created synthetic particles known as dendrimers, which have been used in nanotechnology and pharmaceuticals. In 1992, Tomalia founded his own company, Dendritech. The company was purchased by Dow Chemical in a few years later. In 2001, Tomalia started Dendritic NanoTechnologies at Central Michigan University; Starpharma of Australia provided seed money for the venture and Dow took an equity position a few years later. In 2010, Tomalia founded NanoSynthons, LLC, in Mount Pleasant,Michigan.In 2016, he was named a fellow of the American Association for the Advancement of Science. He has been named a Thomson Reuters Citation Laureate. 活动家作为专业第三方嘉宾邀约平台，依托互联网公开数据为您提供嘉宾信息展示服务。若您发现嘉宾信息需要更新或移除，请发送邮件或联系客服。 我们专注于根据您的具体需求（包括演讲议题、会议日期及活动预算等），为您精准匹配各领域专业嘉宾。 为高效服务，建议您提前准备好详细活动信息，并拨打客服电话：18911802888（工作日9:00-18:00）。 温馨提示：本服务仅限嘉宾邀约相关事宜，其他需求暂不处理，感谢您的理解与配合。